$4.59
3.38% today
Nasdaq, Jul 24, 04:49 pm CET
ISIN
US64131A1051
Symbol
STIM

Neuronetics, Inc. Stock News

Neutral
GlobeNewsWire
9 days ago
Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process
Neutral
GlobeNewsWire
about one month ago
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to one new non-executive employee as described below. In accordance with NASD...
Neutral
GlobeNewsWire
about one month ago
NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company's ongoing commitment to clinical innovation and excellence NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company's ongoing commitment to clinical innovation and excellence
Neutral
GlobeNewsWire
about 2 months ago
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that it is set to join the broad-market Russell 3000® Index ...
Neutral
Seeking Alpha
3 months ago
Neuronetics, Inc. (NASDAQ:STIM ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President & Chief Executive Officer Steve Furlong - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair William Plovanic - Canaccord Genuity Adam Maeder - Piper Sandler Danny Stauder - Citizens J...
Neutral
GlobeNewsWire
3 months ago
MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial and operating r...
Neutral
GlobeNewsWire
3 months ago
MALVERN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 4,500 shares of the Company'...
Neutral
GlobeNewsWire
4 months ago
Policy update increases access for millions covered by Evernorth Health Services Policy update increases access for millions covered by Evernorth Health Services

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today